This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1979;9(2):301-17.

doi: 10.3109/03602537908993896.

Polymorphisms of oxidation at carbon centers of drugs and their clinical significance

J R Idle, R L Smith

PMID: 158499
DOI: 10.3109/03602537908993896

Review

Polymorphisms of oxidation at carbon centers of drugs and their clinical significance

J R Idle et al. Drug Metab Rev. 1979.

. 1979;9(2):301-17.

doi: 10.3109/03602537908993896.

Authors

J R Idle, R L Smith

PMID: 158499
DOI: 10.3109/03602537908993896

No abstract available

PubMed Disclaimer

Similar articles

Genetically determined defcts of oxidation at carbon centres of drugs.
Smith RL, Idle JR, Mahgoub AA, Sloan TP, Lancaster R. Smith RL, et al. Lancet. 1978 Apr 29;1(8070):943-4. doi: 10.1016/s0140-6736(78)90724-9. Lancet. 1978. PMID: 76883 No abstract available.
[Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
Eichelbaum M. Eichelbaum M. Internist (Berl). 1983 Mar;24(3):117-27. Internist (Berl). 1983. PMID: 6135670 Review. German. No abstract available.
Genetic evidence for the involvement of different oxidative mechanisms in drug oxidation.
Wakile LA, Sloan TP, Idle JR, Smith RL. Wakile LA, et al. J Pharm Pharmacol. 1979 May;31(5):350-2. doi: 10.1111/j.2042-7158.1979.tb13520.x. J Pharm Pharmacol. 1979. PMID: 37314 No abstract available.
[Heritable polymorphisms in oxidative drug metabolism].
Kallio J. Kallio J. Duodecim. 1990;106(5):408-14. Duodecim. 1990. PMID: 1670108 Review. Finnish. No abstract available.
Polymorphism of carbon oxidation of drugs and clinical implications.
Sloan TP, Mahgoub A, Lancaster R, Idle JR, Smith RL. Sloan TP, et al. Br Med J. 1978 Sep 2;2(6138):655-7. doi: 10.1136/bmj.2.6138.655. Br Med J. 1978. PMID: 151576 Free PMC article.

See all similar articles

Cited by

Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans.
Eichelbaum M, Woolhouse NM. Eichelbaum M, et al. Eur J Clin Pharmacol. 1985;28(1):79-83. doi: 10.1007/BF00635712. Eur J Clin Pharmacol. 1985. PMID: 3987789
Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites.
Wiesel FA, Raaflaub J, Kettler R. Wiesel FA, et al. Eur J Clin Pharmacol. 1985;28(1):89-95. doi: 10.1007/BF00635714. Eur J Clin Pharmacol. 1985. PMID: 3987791 Clinical Trial.
Defective oxidation of drugs: pharmacokinetic and therapeutic implications.
Eichelbaum M. Eichelbaum M. Clin Pharmacokinet. 1982 Jan-Feb;7(1):1-22. doi: 10.2165/00003088-198207010-00001. Clin Pharmacokinet. 1982. PMID: 7042170 Review. No abstract available.
Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.
Küpfer A, Preisig R. Küpfer A, et al. Eur J Clin Pharmacol. 1984;26(6):753-9. doi: 10.1007/BF00541938. Eur J Clin Pharmacol. 1984. PMID: 6489416
Drug metabolism and pharmacogenetics: the British contribution to fields of international significance.
Caldwell J. Caldwell J. Br J Pharmacol. 2006 Jan;147 Suppl 1(Suppl 1):S89-99. doi: 10.1038/sj.bjp.0706466. Br J Pharmacol. 2006. PMID: 16402125 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon